Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1982 3
1983 1
1984 4
1985 4
1986 6
1987 6
1988 11
1989 5
1990 6
1991 6
1992 2
1993 3
1994 9
1995 4
1996 4
1997 4
1998 7
1999 8
2000 6
2001 9
2002 7
2003 4
2004 9
2005 9
2006 5
2007 5
2008 6
2009 6
2010 13
2011 7
2012 7
2013 13
2014 16
2015 10
2016 7
2017 3
2018 11
2019 13
2020 11
2021 11
2022 4
2023 11
2024 2
2025 8
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

294 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean salmon dj[au] (8 results)?
Mirvetuximab Soravtansine Exposure and Incidence of Cataract Surgery.
Silverstein JF, Smick A, Tsui E, Alomaja O, Johnson B, Tseng CH, Salani R, Slamon DJ, Chase DM, Konecny GE. Silverstein JF, et al. Among authors: slamon dj. JAMA Netw Open. 2026 May 1;9(5):e2614557. doi: 10.1001/jamanetworkopen.2026.14557. JAMA Netw Open. 2026. PMID: 42166161 Free PMC article.
Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomized clinical trial.
Landon BV, Boland JL, Wahner Hendrickson AE, Armstrong DK, Winterhoff B, Wehr J, Annapragada AV, Cherry C, Balan A, Kaleka G, Velculescu VE, Baylin SB, Zahnow CA, Slamon DJ, Konecny GE, Anagnostou V, Glaspy JA. Landon BV, et al. Among authors: slamon dj. Commun Med (Lond). 2026 Feb 6;6(1):142. doi: 10.1038/s43856-026-01404-0. Commun Med (Lond). 2026. PMID: 41652014 Free PMC article.
Adjuvant ribociclib plus nonsteroidal aromatase inhibitor therapy in patients with HR-positive/HER2-negative early breast cancer: 5-year follow-up of NATALEE efficacy outcomes and updated overall survival.
Crown J, Stroyakovskii D, Yardley DA, Huang CS, Fasching PA, Bardia A, Chia S, Im SA, Martin M, Xu B, Barrios CH, Untch M, Moroose R, Hurvitz SA, Hortobagyi GN, Slamon DJ, Visco F, Spera G, Zarate JP, Halligan D, Li Z, Loi S. Crown J, et al. Among authors: slamon dj. ESMO Open. 2025 Nov;10(11):105858. doi: 10.1016/j.esmoop.2025.105858. Epub 2025 Oct 17. ESMO Open. 2025. PMID: 41320342 Free PMC article. Clinical Trial.
Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial.
Fasching PA, Stroyakovskiy D, Yardley DA, Huang CS, Crown J, Bardia A, Chia S, Im SA, Martin M, Xu B, Loi S, Barrios C, Untch M, Moroose R, Visco F, Hortobagyi GN, Slamon DJ, Fresco R, Zarate JP, Li Z, Waters S, Hurvitz SA. Fasching PA, et al. Among authors: slamon dj. JAMA Oncol. 2025 Nov 1;11(11):1364-1372. doi: 10.1001/jamaoncol.2025.3700. JAMA Oncol. 2025. PMID: 40996773 Free PMC article. Clinical Trial.
Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence.
Conforti F, Merlo F, Pala L, Canzian J, Tinterri B, De Pas T, Locatelli M, Dickerson JC, Cortes J, Slamon DJ, Gelber R, Bagnardi V. Conforti F, et al. Among authors: slamon dj. J Clin Oncol. 2025 Oct 20;43(30):3237-3244. doi: 10.1200/JCO-25-01148. Epub 2025 Sep 17. J Clin Oncol. 2025. PMID: 40961402 No abstract available.
Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancer.
Konecny GE, Davidson TM, Lebreton CL, Marsh LA, Chetram DK, Atkinson HJ, Larson MC, Oberg AL, Abdelaal N, Silverstein J, Jatoi A, Washburn A, Burton J, Dowdy S, Zhang L, Hallberg D, Velculescu VE, Slamon DJ, Wahner-Hendrickson AE. Konecny GE, et al. Among authors: slamon dj. Int J Gynecol Cancer. 2025 Oct;35(10):102028. doi: 10.1016/j.ijgc.2025.102028. Epub 2025 Jul 28. Int J Gynecol Cancer. 2025. PMID: 40839974 Free article. Clinical Trial.
Predicting ovarian function loss after chemotherapy and anti-HER2 therapy in young breast cancer patients.
Lambertini M, Allegranza D, Laubender RP, Harbeck N, Swain SM, Geyer CE, Slamon DJ, Bobba G, Lambertini C, de Haas S, Restuccia E, Vaz-Luis I, Cameron DA, Krop IE, Winer EP, Anderson RA. Lambertini M, et al. Among authors: slamon dj. J Natl Cancer Inst. 2025 Nov 1;117(11):2317-2326. doi: 10.1093/jnci/djaf198. J Natl Cancer Inst. 2025. PMID: 40796347 Free PMC article. Clinical Trial.
Tumor Cells Enriched for Interferon and Inflammatory Programs Pre-Exist in High Grade Serous Ovarian Cancer and are Proportionately Significantly Increased Post Chemotherapy.
Winterhoff BJN, Girnius N, Liu M, Kang J, Shetty M, Martinez-Gakidis MA, Xu W, Thomas M, Lahmadi L, Henstridge AZ, Baldominos P, Talukdaer S, Chang Z, Mattson J, Gruner M, Mullany SA, Argenta P, Konecny GE, Slamon DJ, Drapkin R, Nelson AC, Starr TK, Brugge JS. Winterhoff BJN, et al. Among authors: slamon dj. bioRxiv [Preprint]. 2025 Jun 25:2025.06.24.661404. doi: 10.1101/2025.06.24.661404. bioRxiv. 2025. PMID: 40667229 Free PMC article. Preprint.
294 results